Drug-carrier interaction analysis in the cell penetrating peptide-modified liposomes for doxorubicin loading

被引:5
作者
Liu, Chang [1 ]
Luo, Qi [2 ,3 ]
Tu, YingFeng [1 ]
Wang, GuiLing [1 ]
Liu, YingChun [2 ,3 ]
Xie, Ying [1 ]
机构
[1] Peking Univ, Sch Pharmaceut Sci, Dept Pharmaceut, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China
[2] Zhejiang Univ, Soft Matter Res Ctr, Hangzhou 310027, Zhejiang, Peoples R China
[3] Zhejiang Univ, Dept Chem, Hangzhou 310027, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Cell-penetrating peptide; doxorubicin; interaction mechanism; liposomes; molecular dynamics simulation; MOLECULAR-DYNAMICS; PI INTERACTIONS; DNA; DELIVERY; SIMULATIONS; EFFICIENT; PROTEINS; SYSTEMS; CANCER;
D O I
10.3109/02652048.2015.1073390
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Doxorubicin (DOX) is widely used as an antitumor model drug in liposomes because of its high encapsulation efficiency. The cell-penetrating peptide (CPP) has potential applications in drug delivery systems. However, we discovered that the encapsulation efficiency of DOX decreased with increasing modification density of CPP on liposomes. To explore the interaction mechanisms of CPP-modified liposomes (CPPL) for DOX loading, X-ray diffraction, Fourier transform infrared spectroscopy and Raman spectroscopy were utilised, and theoretical calculations based on molecular dynamics simulation were performed. Results showed that the monomeric intermolecular interaction between CPP and DOX, in which the guanidinium group of CPP was parallel to the planar aromatic chromophore of DOX, depending on the cation-pi interaction and hydrogen bonds, weakened the tendency of DOX transporting into the internal medium from the liposomal external medium. Analysis of the interaction between CPP and DOX at the molecular level provided theoretical guidance for the further development of CPPL.
引用
收藏
页码:745 / 754
页数:10
相关论文
共 34 条
[1]  
Allen TM, 2002, CELL MOL BIOL LETT, V7, P889
[2]   In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization:: Effects of PEG chain length and PC incorporation [J].
Ashok, B ;
Arleth, L ;
Hjelm, RP ;
Rubinstein, I ;
Önyüksel, H .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (10) :2476-2487
[3]   Doxil® - The first FDA-approved nano-drug: Lessons learned [J].
Barenholz, Yechezkel .
JOURNAL OF CONTROLLED RELEASE, 2012, 160 (02) :117-134
[4]   Octa-arginine-modified pegylated liposomal doxorubicin: An effective treatment strategy for non-small cell lung cancer [J].
Biswas, Swati ;
Deshpande, Pranali P. ;
Perche, Federico ;
Dodwadkar, Namita S. ;
Sane, Shailendra D. ;
Torchilin, Vladimir P. .
CANCER LETTERS, 2013, 335 (01) :191-200
[5]   PARTICLE MESH EWALD - AN N.LOG(N) METHOD FOR EWALD SUMS IN LARGE SYSTEMS [J].
DARDEN, T ;
YORK, D ;
PEDERSEN, L .
JOURNAL OF CHEMICAL PHYSICS, 1993, 98 (12) :10089-10092
[6]   A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations [J].
Duan, Y ;
Wu, C ;
Chowdhury, S ;
Lee, MC ;
Xiong, GM ;
Zhang, W ;
Yang, R ;
Cieplak, P ;
Luo, R ;
Lee, T ;
Caldwell, J ;
Wang, JM ;
Kollman, P .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2003, 24 (16) :1999-2012
[7]   Delivery of Macromolecules Using Arginine-Rich Cell-Penetrating Peptides: Ways to Overcome Endosomal Entrapment [J].
El-Sayed, Ayman ;
Futaki, Shiroh ;
Harashima, Hideyoshi .
AAPS JOURNAL, 2009, 11 (01) :13-22
[8]   A calorimetric study of dimyristoylphosphatidylcholine phase transitions and steroid-liposome interactions for liposomes prepared by thin film and proliposome methods [J].
Elhissi, A. M. A. ;
O'Neill, M. A. A. ;
Roberts, S. A. ;
Taylor, K. M. G. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 320 (1-2) :124-130
[9]  
FORNARI FA, 1994, MOL PHARMACOL, V45, P649
[10]   Cation-π interactions in structural biology [J].
Gallivan, JP ;
Dougherty, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (17) :9459-9464